Open AccessNivolumab (Opdivo)
Author(s) -
CADTH
Publication year - 2022
Publication title -
canadian journal of health technologies
Language(s) - Uncategorized
Resource type - Journals
ISSN - 2563-6596
DOI - 10.51731/cjht.2022.403
Subject(s) - reimbursement , nivolumab , medicine , oncology , drug , esophageal adenocarcinoma , gastroesophageal junction , adenocarcinoma , intensive care medicine , pharmacology , cancer , political science , immunotherapy , health care , law